---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-089972"
form_type: "8-K"
ticker: "REVB"
cik: "0001810560"
company_name: "REVELATION BIOSCIENCES, INC."
filed_at: "2025-06-25T23:59:59+00:00"
generated_at: "2026-05-18T19:46:03.986966+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Revelation Bio shareholders approve reverse split up to 1:250; Nevada reincorporation fails despite 89% support

## Summary
- Reverse stock split authorized at ratio 1:2 to 1:250, board to set exact ratio within one year.
- Issuance of common stock under May 2025 Class H Warrants above 20% exchange cap approved.
- Reincorporation from Delaware to Nevada failed (89% of votes cast in favor, but not enough outstanding shares).
- Lakhmir Chawla elected Class C director; advisory votes on exec compensation and frequency (3 years) passed.
- Baker Tilly US ratified as auditor for FY2025; CEO presentation given but details not disclosed.

## SEC filing metadata
- accession: 0000950170-25-089972
- form_type: 8-K
- ticker: REVB
- cik: 0001810560
- company_name: REVELATION BIOSCIENCES, INC.
- filed_at: 2025-06-25T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810560/000095017025089972/0000950170-25-089972-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810560/000095017025089972/revb-20250623.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-089972
- JSON: https://secwatch.observer/filing/0000950170-25-089972.json
- Plain text: https://secwatch.observer/filing/0000950170-25-089972.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.